ARP3_HUMAN - dbPTM
ARP3_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID ARP3_HUMAN
UniProt AC P61158
Protein Name Actin-related protein 3
Gene Name ACTR3
Organism Homo sapiens (Human).
Sequence Length 418
Subcellular Localization Cytoplasm, cytoskeleton . Cell projection . In pre-apoptotic cells, colocalizes with MEFV in large specks (pyroptosomes) (PubMed:19109554).
Protein Description Functions as ATP-binding component of the Arp2/3 complex which is involved in regulation of actin polymerization and together with an activating nucleation-promoting factor (NPF) mediates the formation of branched actin networks. Seems to contact the pointed end of the daughter actin filament. Plays a role in ciliogenesis..
Protein Sequence MAGRLPACVVDCGTGYTKLGYAGNTEPQFIIPSCIAIKESAKVGDQAQRRVMKGVDDLDFFIGDEAIEKPTYATKWPIRHGIVEDWDLMERFMEQVIFKYLRAEPEDHYFLLTEPPLNTPENREYTAEIMFESFNVPGLYIAVQAVLALAASWTSRQVGERTLTGTVIDSGDGVTHVIPVAEGYVIGSCIKHIPIAGRDITYFIQQLLRDREVGIPPEQSLETAKAVKERYSYVCPDLVKEFNKYDTDGSKWIKQYTGINAISKKEFSIDVGYERFLGPEIFFHPEFANPDFTQPISEVVDEVIQNCPIDVRRPLYKNIVLSGGSTMFRDFGRRLQRDLKRTVDARLKLSEELSGGRLKPKPIDVQVITHHMQRYAVWFGGSMLASTPEFYQVCHTKKDYEEIGPSICRHNPVFGVMS
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
2Acetylation------MAGRLPACV
------CCCCCCEEE
16.2919413330
8S-nitrosylationMAGRLPACVVDCGTG
CCCCCCEEEEECCCC
2.642212679
8S-palmitoylationMAGRLPACVVDCGTG
CCCCCCEEEEECCCC
2.6426865113
12S-nitrosylationLPACVVDCGTGYTKL
CCEEEEECCCCCEEC
3.382212679
12S-palmitoylationLPACVVDCGTGYTKL
CCEEEEECCCCCEEC
3.3826865113
14PhosphorylationACVVDCGTGYTKLGY
EEEEECCCCCEECCC
33.0928442448
16NitrationVVDCGTGYTKLGYAG
EEECCCCCEECCCCC
10.67-
16PhosphorylationVVDCGTGYTKLGYAG
EEECCCCCEECCCCC
10.6727155012
17PhosphorylationVDCGTGYTKLGYAGN
EECCCCCEECCCCCC
22.5728152594
18UbiquitinationDCGTGYTKLGYAGNT
ECCCCCEECCCCCCC
31.28-
25PhosphorylationKLGYAGNTEPQFIIP
ECCCCCCCCCCEECC
48.3928348404
38AcetylationIPSCIAIKESAKVGD
CCCCEEEHHHHCCCH
36.2725953088
38UbiquitinationIPSCIAIKESAKVGD
CCCCEEEHHHHCCCH
36.27-
42AcetylationIAIKESAKVGDQAQR
EEEHHHHCCCHHHHH
56.9025953088
42UbiquitinationIAIKESAKVGDQAQR
EEEHHHHCCCHHHHH
56.9021906983
53AcetylationQAQRRVMKGVDDLDF
HHHHHHHCCCCCCCE
53.5823954790
53UbiquitinationQAQRRVMKGVDDLDF
HHHHHHHCCCCCCCE
53.5821906983
53UbiquitinationQAQRRVMKGVDDLDF
HHHHHHHCCCCCCCE
53.5821890473
69AcetylationIGDEAIEKPTYATKW
CCHHHCCCCCCCCCC
36.2226051181
69UbiquitinationIGDEAIEKPTYATKW
CCHHHCCCCCCCCCC
36.2221906983
69UbiquitinationIGDEAIEKPTYATKW
CCHHHCCCCCCCCCC
36.2221890473
75UbiquitinationEKPTYATKWPIRHGI
CCCCCCCCCCCCCCC
42.6821906983
89SulfoxidationIVEDWDLMERFMEQV
CCCCHHHHHHHHHHH
3.0130846556
99UbiquitinationFMEQVIFKYLRAEPE
HHHHHHHHHHHCCCC
32.0521906983
99UbiquitinationFMEQVIFKYLRAEPE
HHHHHHHHHHHCCCC
32.0521890473
100PhosphorylationMEQVIFKYLRAEPED
HHHHHHHHHHCCCCC
7.2322817900
109PhosphorylationRAEPEDHYFLLTEPP
HCCCCCCEEECCCCC
14.2917360941
113PhosphorylationEDHYFLLTEPPLNTP
CCCEEECCCCCCCCC
48.9029255136
119PhosphorylationLTEPPLNTPENREYT
CCCCCCCCCCCCCEE
39.4029255136
133PhosphorylationTAEIMFESFNVPGLY
EEEEEEHHCCCCHHH
15.74-
140PhosphorylationSFNVPGLYIAVQAVL
HCCCCHHHHHHHHHH
7.86-
152PhosphorylationAVLALAASWTSRQVG
HHHHHHHHHHCCCCC
25.86-
184PhosphorylationVIPVAEGYVIGSCIK
EEEECCCEEEHHHHH
4.7620090780
188PhosphorylationAEGYVIGSCIKHIPI
CCCEEEHHHHHCCCC
11.09-
189S-palmitoylationEGYVIGSCIKHIPIA
CCEEEHHHHHCCCCC
3.9729575903
191AcetylationYVIGSCIKHIPIAGR
EEEHHHHHCCCCCCC
39.5526051181
191UbiquitinationYVIGSCIKHIPIAGR
EEEHHHHHCCCCCCC
39.55-
201PhosphorylationPIAGRDITYFIQQLL
CCCCCHHHHHHHHHH
19.3728450419
202PhosphorylationIAGRDITYFIQQLLR
CCCCHHHHHHHHHHH
10.0622115753
225AcetylationEQSLETAKAVKERYS
HHHHHHHHHHHHHHH
62.2225953088
225UbiquitinationEQSLETAKAVKERYS
HHHHHHHHHHHHHHH
62.2221906983
228UbiquitinationLETAKAVKERYSYVC
HHHHHHHHHHHHCCC
41.14-
231PhosphorylationAKAVKERYSYVCPDL
HHHHHHHHHCCCHHH
12.8721082442
232PhosphorylationKAVKERYSYVCPDLV
HHHHHHHHCCCHHHH
19.8128152594
233PhosphorylationAVKERYSYVCPDLVK
HHHHHHHCCCHHHHH
9.3528152594
2402-HydroxyisobutyrylationYVCPDLVKEFNKYDT
CCCHHHHHHHHHCCC
64.98-
240AcetylationYVCPDLVKEFNKYDT
CCCHHHHHHHHHCCC
64.9819608861
240MalonylationYVCPDLVKEFNKYDT
CCCHHHHHHHHHCCC
64.9826320211
240UbiquitinationYVCPDLVKEFNKYDT
CCCHHHHHHHHHCCC
64.9821890473
240UbiquitinationYVCPDLVKEFNKYDT
CCCHHHHHHHHHCCC
64.9821890473
2442-HydroxyisobutyrylationDLVKEFNKYDTDGSK
HHHHHHHHCCCCCHH
50.23-
244AcetylationDLVKEFNKYDTDGSK
HHHHHHHHCCCCCHH
50.2319608861
244MalonylationDLVKEFNKYDTDGSK
HHHHHHHHCCCCCHH
50.2326320211
244UbiquitinationDLVKEFNKYDTDGSK
HHHHHHHHCCCCCHH
50.2319608861
251AcetylationKYDTDGSKWIKQYTG
HCCCCCHHHHHHHHC
59.4719608861
251MalonylationKYDTDGSKWIKQYTG
HCCCCCHHHHHHHHC
59.4726320211
251UbiquitinationKYDTDGSKWIKQYTG
HCCCCCHHHHHHHHC
59.4721890473
251UbiquitinationKYDTDGSKWIKQYTG
HCCCCCHHHHHHHHC
59.4721890473
2542-HydroxyisobutyrylationTDGSKWIKQYTGINA
CCCHHHHHHHHCCCC
35.82-
254AcetylationTDGSKWIKQYTGINA
CCCHHHHHHHHCCCC
35.8219608861
254MalonylationTDGSKWIKQYTGINA
CCCHHHHHHHHCCCC
35.8226320211
254UbiquitinationTDGSKWIKQYTGINA
CCCHHHHHHHHCCCC
35.8221890473
254UbiquitinationTDGSKWIKQYTGINA
CCCHHHHHHHHCCCC
35.8221890473
256PhosphorylationGSKWIKQYTGINAIS
CHHHHHHHHCCCCCC
11.2628152594
257PhosphorylationSKWIKQYTGINAISK
HHHHHHHHCCCCCCC
29.1428152594
264SumoylationTGINAISKKEFSIDV
HCCCCCCCCEEEEEC
50.65-
2642-HydroxyisobutyrylationTGINAISKKEFSIDV
HCCCCCCCCEEEEEC
50.65-
264AcetylationTGINAISKKEFSIDV
HCCCCCCCCEEEEEC
50.6525953088
264SuccinylationTGINAISKKEFSIDV
HCCCCCCCCEEEEEC
50.6523954790
264SumoylationTGINAISKKEFSIDV
HCCCCCCCCEEEEEC
50.65-
264UbiquitinationTGINAISKKEFSIDV
HCCCCCCCCEEEEEC
50.65-
265UbiquitinationGINAISKKEFSIDVG
CCCCCCCCEEEEECC
58.1421906983
265UbiquitinationGINAISKKEFSIDVG
CCCCCCCCEEEEECC
58.1421890473
268PhosphorylationAISKKEFSIDVGYER
CCCCCEEEEECCCHH
20.9724719451
273PhosphorylationEFSIDVGYERFLGPE
EEEEECCCHHHCCCE
12.0928152594
317AcetylationDVRRPLYKNIVLSGG
CCCCCCCCCEEECCC
48.1325953088
317UbiquitinationDVRRPLYKNIVLSGG
CCCCCCCCCEEECCC
48.13-
322PhosphorylationLYKNIVLSGGSTMFR
CCCCEEECCCCHHHH
30.1630108239
325PhosphorylationNIVLSGGSTMFRDFG
CEEECCCCHHHHHHH
21.8930108239
326PhosphorylationIVLSGGSTMFRDFGR
EEECCCCHHHHHHHH
24.4930108239
327SulfoxidationVLSGGSTMFRDFGRR
EECCCCHHHHHHHHH
2.5130846556
3482-HydroxyisobutyrylationRTVDARLKLSEELSG
HHHHHHHHCCHHHCC
44.40-
348AcetylationRTVDARLKLSEELSG
HHHHHHHHCCHHHCC
44.4025953088
348MalonylationRTVDARLKLSEELSG
HHHHHHHHCCHHHCC
44.4026320211
348UbiquitinationRTVDARLKLSEELSG
HHHHHHHHCCHHHCC
44.4021906983
350PhosphorylationVDARLKLSEELSGGR
HHHHHHCCHHHCCCC
27.6923911959
354PhosphorylationLKLSEELSGGRLKPK
HHCCHHHCCCCCCCC
42.3427251275
359UbiquitinationELSGGRLKPKPIDVQ
HHCCCCCCCCCCCHH
50.0321906983
359UbiquitinationELSGGRLKPKPIDVQ
HHCCCCCCCCCCCHH
50.0321890473
361UbiquitinationSGGRLKPKPIDVQVI
CCCCCCCCCCCHHHH
53.6821906983
361UbiquitinationSGGRLKPKPIDVQVI
CCCCCCCCCCCHHHH
53.6821890473
375PhosphorylationITHHMQRYAVWFGGS
HCCCHHHHHHHHCCC
6.6620068231
383SulfoxidationAVWFGGSMLASTPEF
HHHHCCCHHCCCHHH
4.0230846556
387PhosphorylationGGSMLASTPEFYQVC
CCCHHCCCHHHHHHH
22.6420068231
391PhosphorylationLASTPEFYQVCHTKK
HCCCHHHHHHHCCCC
9.8120068231
396PhosphorylationEFYQVCHTKKDYEEI
HHHHHHCCCCCHHHH
34.3620068231
3982-HydroxyisobutyrylationYQVCHTKKDYEEIGP
HHHHCCCCCHHHHCH
67.70-
398AcetylationYQVCHTKKDYEEIGP
HHHHCCCCCHHHHCH
67.7026051181
398MalonylationYQVCHTKKDYEEIGP
HHHHCCCCCHHHHCH
67.7026320211
398SuccinylationYQVCHTKKDYEEIGP
HHHHCCCCCHHHHCH
67.7023954790
398UbiquitinationYQVCHTKKDYEEIGP
HHHHCCCCCHHHHCH
67.70-
400PhosphorylationVCHTKKDYEEIGPSI
HHCCCCCHHHHCHHH
25.0928152594
406PhosphorylationDYEEIGPSICRHNPV
CHHHHCHHHHCCCCC
29.1620068231
408GlutathionylationEEIGPSICRHNPVFG
HHHCHHHHCCCCCCC
4.2022555962
417SulfoxidationHNPVFGVMS------
CCCCCCCCC------
3.9428183972
418PhosphorylationNPVFGVMS-------
CCCCCCCC-------
34.3625159151

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources

Oops, there are no upstream regulatory protein records of ARP3_HUMAN !!

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of ARP3_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of ARP3_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
ARP2_HUMANACTR2physical
11741539
ARC1B_HUMANARPC1Bphysical
11741539
ARPC2_HUMANARPC2physical
11741539
ARPC3_HUMANARPC3physical
11741539
ARPC4_HUMANARPC4physical
11741539
SRC8_HUMANCTTNphysical
12176742
ARPC2_HUMANARPC2physical
22939629
ARPC4_HUMANARPC4physical
22939629
ARPC3_HUMANARPC3physical
22939629
ARPC5_HUMANARPC5physical
22939629
ARP5L_HUMANARPC5Lphysical
22939629
ARPC4_HUMANARPC4physical
22863883
ARPC5_HUMANARPC5physical
22863883
CALU_HUMANCALUphysical
22863883
FUBP1_HUMANFUBP1physical
22863883
KBP_HUMANKIAA1279physical
22863883
TRMB_HUMANMETTL1physical
22863883
NIF3L_HUMANNIF3L1physical
22863883
NSUN2_HUMANNSUN2physical
22863883
KAPCB_HUMANPRKACBphysical
22863883
RAGP1_HUMANRANGAP1physical
22863883
RFA1_HUMANRPA1physical
22863883
RPR1B_HUMANRPRD1Bphysical
22863883
SHLB1_HUMANSH3GLB1physical
22863883
PRPK_HUMANTP53RKphysical
22863883
TPD54_HUMANTPD52L2physical
22863883
TPRKB_HUMANTPRKBphysical
22863883
UGGG1_HUMANUGGT1physical
22863883
ZPR1_HUMANZPR1physical
22863883
RHG17_HUMANARHGAP17physical
26344197
COG3_HUMANCOG3physical
26344197
COR1B_HUMANCORO1Bphysical
26344197
STXB1_HUMANSTXBP1physical
26344197
ARP2_HUMANACTR2physical
28514442
CYTN_HUMANCST1physical
28514442
CYTS_HUMANCST4physical
28514442
ARPC2_HUMANARPC2physical
28514442
ARP5L_HUMANARPC5Lphysical
28514442
ARPC4_HUMANARPC4physical
28514442
TCPB_HUMANCCT2physical
28514442
TCPH_HUMANCCT7physical
28514442
TCPG_HUMANCCT3physical
28514442
TCPZ_HUMANCCT6Aphysical
28514442
TCPD_HUMANCCT4physical
28514442

Drug and Disease Associations
Kegg Disease
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of ARP3_HUMAN

loading...

Related Literatures of Post-Translational Modification
Acetylation
ReferencePubMed
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach.";
Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.;
Anal. Chem. 81:4493-4501(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, AND MASS SPECTROMETRY.
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions.";
Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.;
Science 325:834-840(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-240; LYS-244; LYS-251 ANDLYS-254, AND MASS SPECTROMETRY.
Phosphorylation
ReferencePubMed
"Global survey of phosphotyrosine signaling identifies oncogenickinases in lung cancer.";
Rikova K., Guo A., Zeng Q., Possemato A., Yu J., Haack H., Nardone J.,Lee K., Reeves C., Li Y., Hu Y., Tan Z., Stokes M., Sullivan L.,Mitchell J., Wetzel R., Macneill J., Ren J.M., Yuan J.,Bakalarski C.E., Villen J., Kornhauser J.M., Smith B., Li D., Zhou X.,Gygi S.P., Gu T.-L., Polakiewicz R.D., Rush J., Comb M.J.;
Cell 131:1190-1203(2007).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-16; TYR-202 AND TYR-231,AND MASS SPECTROMETRY.
"Immunoaffinity profiling of tyrosine phosphorylation in cancercells.";
Rush J., Moritz A., Lee K.A., Guo A., Goss V.L., Spek E.J., Zhang H.,Zha X.-M., Polakiewicz R.D., Comb M.J.;
Nat. Biotechnol. 23:94-101(2005).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-231, AND MASSSPECTROMETRY.

TOP